The growth is due to evolution of market owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global research antibodies and reagents market is expected to witness significant growth in the coming years.
The report Research Antibodies & Reagents Market is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period. Ask for PDF Brochure: –https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793 COVID-19 Impact: - The COVID-19 outbreak has boosted research activity due to efforts to understand the dynamics of the infection. We estimate that the major share of research antibody and reagent manufacturing, along with personalized medicine, will grow at a stable pace in the next five years. Due to the increase in research activity, both the availability of funding for research and the demand & manufacturing of reagents and antibodies are expected to grow. As companies after pandemic have scaled up their operations for testing and tracking the infection of COVID-19. This has given a chance for growth in profits for companies operating in the NGS and PCR markets. The growth in revenue is 5–7%, as COVID-19 testing has increased with the use of the latest technology of genetic and molecular testing. The shift in demand for research for COVID-19, neurobiology, and oncology has created a huge scope for testing solutions, such as western blotting, flow cytometry, ELISA, and drugs for researchers and laboratories. Market Segmentation: - Based on product, the research antibodies market is segmented into reagents and antibodies. The antibodies segment is expected to grow at highest CAGR in forecast period. This is due to the research-use antibodies offer high specificity and selectivity and are used ubiquitously in biochemical and medical research for protein-target identification, regulatory characterization, and discovery. Based type, the research reagents market is segmented into primary antibodies and secondary antibodies. The primary antibodies segment held the largest share of the global research antibodies market in 2019. Based type, the research antibodies market is segmented into media &sera, stains & dyes, fixatives, buffers, solvents, enzymes, probes and other reagents. The media & sera reagent segment held the largest share of the global research antibodies market in 2019. Based on technology, the research antibodies and reagents market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. Western blotting segment is expected to grow at highest CAGR in forecast periods (2020-2025). Based on end user, the research reagents market is segmented into the pharmaceutical & biotechnology companies, academic & research institutions and Contract Research Organizations. Request for sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=94212793 Regional Analysis:- The Asia Pacific research antibodies and reagents market is expected to grow at the highest CAGR from 2020 to 2025. Also, high-growth countries, such as China, India, Japan, South Korea, Taiwan, Australia, and Singapore are the major contributors to the Asia Pacific research antibodies and reagents market.
0 Comments
High prevalence of ophthalmic disorders, rapid growth in geriatric population, technological advancements, increasing regulatory approvals for ophthalmic lasers, rising prevalence of chronic diseases such as diabetes, and increasing initiatives to control visual impairment are expected to drive the growth of the global ophthalmic lasers market in the coming years.
The Ophthalmic Lasers Market is expected to reach USD 1,245.4 Million by 2021 from USD 970.2 Million in 2016, at a CAGR of 5.1% from 2016 to 2021. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=251971654 Market Segmentation:- The global ophthalmic lasers market is segmented on the basis of product types, applications, end users, and regions. Based on product type, the ophthalmic lasers market is categorized into femtosecond lasers, excimer lasers, Nd:YAG lasers, diode lasers, and others. The femtosecond lasers segment is expected to command the largest share of the global ophthalmic lasers market, by product type and is projected to grow at the highest CAGR during the forecast period. Based on applications, the ophthalmology lasers market is segmented into refractive error correction, cataract removal, glaucoma treatment, diabetic retinopathy treatment, AMD treatment, and other applications. In 2016, the refractive error correction segment is expected to command the largest share of the global ophthalmic lasers market. Based on end users, the ophthalmic lasers market is segmented into hospitals and clinics & ambulatory surgery centers (ASCs). The hospitals segment is projected to command the largest share of the global ophthalmic lasers market. Key Market Drivers:- 1 High Prevalence of Ophthalmic Disorders 2 Rapid Growth in Geriatric Population 3 Technological Advancements and Increasing Regulatory Approvals for Ophthalmic Lasers 4 Rising Prevalence of Chronic Diseases Such as Diabetes 5 Increasing Initiatives to Control Visual Impairment Regional Analysis:- Based on regions, the ophthalmology lasers market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is expected to account for the largest share of the global ophthalmic lasers market. Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=251971654 Key Market Players:- Alcon Laboratories, Inc. (U.S.), Abbott Medical Optics, Inc. (U.S.), Carl Zeiss Meditec AG (Germany), Bausch & Lomb Incorporated (U.S.), Ellex Medical Lasers Limited (Australia), Topcon Corporation (Japan), Ziemer Ophthalmic Systems AG (Switzerland), IRIDEX Corporation (U.S.), NIDEK Co., Ltd. (Japan), and Lumenis Ltd. (Israel) are some of the key players in the ophthalmic lasers market. Growth in this market is driven mainly by high incidence of nerve injuries, the growing prevalence of neurological disorders, and rising government support for neurologic disorder research.
The global Nerve Repair and Regeneration Market size is projected to reach USD 9.7 billion by 2025 from USD 6.3 billion in 2020, growing at a CAGR of 9.1% from 2020 to 2025. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883 Market Segmentation: - By product, the nerve repair market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment is segment is expected to grow at the highest growth rate during the forecast period. The large market share of this segment is driven mainly by rising government expenditure for neurologic disorders, and favorable reimbursement. Based on the neurostimulation and neuromodulation application, the nerve regeneration market is segmented the neurostimulation and neuromodulation devices market is segmented into internal neurostimulation and neuromodulation applications and external neurostimulation and neuromodulation applications. The internal neurostimulation and neuromodulation segment is estimated to register the highest CAGR during the forecast period. Based on application, the biomaterials market is segmented into direct nerve repair/neurorrhaphy, nerve grafting, and stem cell therapy. In 2019, the direct nerve repair segment accounted for the largest share of the market. Recent Developments: -
Regional Analysis: - The nerve repair market is segmented into five major regions, namely, Europe, North America, the Asia Pacific, Latin America, and Middle East & Africa. In 2019, North America accounted for the largest share of the nerve repair and regeneration industry, followed by Europe. Request for Sample Pages : - https://www.marketsandmarkets.com/requestsampleNew.asp?id=883 Top Key Players: - Some of the major players operating in the global nerve repair market include Medtronic, PLC. (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), AxoGen, Inc. (US), Baxter International, Inc. (US), LivaNova, PLC. (UK), Integra LifeSciences (US), Polyganics (Netherlands), NeuroPace, Inc. (US), Soterix Medical, Inc. (US), Nevro Corp (US), Synapse Biomedical, Inc. (US), Aleva Neurotherapeutics (Switzerland), Collagen Matrix, Inc. (US), KeriMedical (Switzerland), BioWave Corporation (US), NeuroSigma (US), tVNS Technologies GmbH(Germany), and GiMer Medical (Taiwan). The growing adoption of smartphones, increasing penetration of 3G/4G networks, rising focus on cost containment in healthcare delivery, and the increasing demand for home healthcare services are some of the key factors driving the growth of this market.
The report mHealth Solutions Market is projected to reach USD 213.6 billion by 2025 from USD 50.8 billion in 2020, at a CAGR of 33.3 % during the forecast period. Ask for PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1232 Market Segmentation:- Based on product and service, the Mobile Health Apps Market segment accounted for the largest share of the mHealth solutions market in 2019. The large share of this segment can be attributed to the high and growing penetration of smartphones and healthcare apps and the rising incidence of chronic and lifestyle-related diseases across the globe (coupled with the effective utilization of apps in chronic disease management). Key Market Drivers :- 1 Increasing Penetration of Smartphones, Tablets, and Other Mobile Platforms 2 Increasing Utilization of Connected Devices and mHealth Apps for the Management of Chronic Diseases 3 Cost Containment in Healthcare Delivery 4 Robust Penetration of 3G and 4G Networks for Uninterrupted Healthcare Services 5 Rising Focus on Patient-Centric Healthcare Delivery 6 Increasing Demand for Home Healthcare Services Regional Analysis:- Based on region, the Medical Apps Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest market share in 2019. Request for Sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=1232 Top Key Players:- The prominent players in the Mobile Health Apps Market are Medtronic plc (Ireland), Apple, Inc. (US), AirStrip Technologies (US), AliveCor, Inc. (US), Nike, Inc. (US), Koninklijke Philips N.V. (Netherlands), Johnson & Johnson (US), Omron Corporation (Japan), BioTelemetry, Inc. (US), athenahealth, Inc. (US), AgaMatrix, Inc. (US), Withings S.A. (France), and iHealth Labs, Inc. (US). Market growth is largely driven by the rapidly growing global geriatric population. The elderly are more susceptible to various diseases and disorders such as orthopedic, dental, neurological, and cardiovascular disorders, owing to which, growth in the geriatric population will result in an increase in the demand for implants. The growing number of accidents and sports-related injuries and the increasing launch of technologically advanced products are also major factors supporting market growth.
The global Medical Alloys Market is projected to reach USD 17.6 billion by 2024 from USD 11.2 billion in 2019, at a CAGR of 9.4%. Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256117768 By type, the titanium segment is expected to account for the largest share of the metal implants and medical alloys market in 2019 On the basis of type, the titanium segment is expected to account for the largest share of the metal implants and medical alloys market in 2019. The large share of this segment can be attributed to the advantages offered by titanium, such as high biocompatibility, strength, rigidity, greater strain-bearing capacity, and greater corrosion-resistance properties as compared to other materials. Moreover, it is non-allergic, non-magnetic, and non-radio-opaque, and adheres easily to the bone without any additional coating. By application, the orthopedic applications segment is expected to grow at the highest CAGR during the forecast period (2019–2024) Based on application, the metal implants and medical alloys market is segmented into orthopedic, cardiovascular, dental, craniomaxillofacial, and neurological applications. The orthopedic applications segment is expected to grow at the highest CAGR in the metal implants and medical alloys market during the forecast period owing to the growing incidence of orthopedic disorders such as osteoporosis and arthritis, which result in a large patient pool for orthopedic implant procedures. North America to dominate the metal implants and medical alloys market in 2019 North America is expected to account for the largest share of the metal implants and medical alloys market in 2019, followed by Europe and the Asia Pacific. The large share of North America in the global market can be attributed to the growing aging population and subsequent increase in the prevalence of chronic disorders in North American countries, thereby increasing demand for improved products and treatment services. Other factors supporting market growth include the growing healthcare expenditure, high accessibility to advanced technologies in countries such as the US and Canada, increasing focus on the development of innovative and technologically advanced products, and the significant presence of major product developers in the region. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=256117768 The prominent players in the metal implants and medical alloys market are Carpenter Technology Corporation (US), Royal DSM (Netherlands), Johnson Matthey Plc (UK), ATI Specialty Alloys & Components (US), Ametek Specialty Products (US), Aperam S.A. (Luxembourg), QuesTek Innovations LLC (US), and Fort Wayne Metals (US). The rising demand for ambulatory infusion pumps in home care settings, increasing incidence of chronic diseases along with the rapid growth of the geriatric population, and growing number of surgical procedures performed are the major factors driving the growth of this market.
[350 Pages Report] The global Infusion Pump Market is projected to reach USD 18.9 billion by 2025 from USD 13.5 billion in 2020, at a CAGR of 7.0% during the forecast period. Ask for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506 Market Segmentation: - Based on products, the Infusion Pumps Accessories Market is segmented into accessories & consumables and devices. The accessories & consumables segment is expected to grow at the highest CAGR during the forecast period. Based on product, the infusion pumps market is segmented into dedicated accessories & consumables and non-dedicated accessories & consumables. The dedicated accessories & consumables segment is expected to grow at the highest CAGR during the forecast period. Based on type, the Infusion Pumps Accessories Market has been segmented into traditional infusion pumps and specialty infusion pumps market. The specialty infusion pumps segment is expected to grow at the highest CAGR during the forecast period. Based on application, the Infusion Pumps Accessories Market is segmented into chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other applications (includes infectious diseases, autoimmune diseases, and diseases of the heart, kidney, lung, and liver). On the basis of end user, the infusion pumps market has been segmented into hospitals, home care settings, ambulatory care settings, and academic and research institutes. Key Market Drivers: – 1 Rising demand for ambulatory infusion pumps in home care settings 2 Increasing incidence of chronic diseases along with the rapid growth of the geriatric population 3 Growing numbers of surgical procedures performed Regional Analysis: - North America accounted for the largest share of the infusion pumps market in 2019, followed by Europe. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=90374506 Key market Players: - The prominent players in this market are Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), ICU Medical, Inc. (US), Medtronic plc (Ireland), Mindray Medical International Limited (China), Micrel Medical Devices SA (Greece), and Ypsomed Holding AG (Switzerland), among other key players. The growing investments in the pharmaceutical R&D, rising food safety concerns, increasing adoption of gas chromatography in oil & gas industry and policies to reduce environmental pollution levels are the key drivers of the chromatography instruments market growth. Increasing burden on healthcare systems owing to the COVID-19 pandemic worldwide and growing importance of chromatography tests in drug approval process will further upsurge the demand for chromatography instruments.
The report Chromatography Instruments Market is expected to reach USD 11.0 billion by 2025 from USD 8.6 billion in 2020, at a CAGR of 5.1%. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1258 The chromatography instruments market includes Tier I and II vendors like Agilent Technologies, Shimadzu Corporation, Waters Corporation, Thermo Fisher Scientific and PerkinElmer among others. The companies have a large market spread across various countries in North America, Europe, Asia Pacific and Rest of the World. The global COVID-19 outbreak has impacted the business to a certain extent as multiple manufacturing facilities of players were shut down during the lockdown. Despite of the challenging situation, industries are gradually recovering from the impact of the pandemic. As the supply and distribution channels are beginning to open up, business operations are likely to rise at a slow and steady rate in the near future. Thus, the pandemic is not estimated to have long-term effects on the fundamental growth drivers of the chromatography instruments market. It is estimated that market reconciliation and development would be seen toward the beginning of 2021. Liquid chromatography systems segment is anticipated to be the fastest growing segment during the forecast period The market is segmented by type, into liquid chromatography (LC) systems, gas chromatography (GC) systems, supercritical fluid chromatography (SFC) systems and thin-layer chromatography (TLC) systems.. The liquid chromatography systems segment is estimated to command the largest share of the market in 2020, and is projected to register the highest CAGR during the forecast period. Increasing demand for liquid chromatography systems in pharma and biotech industries along with growing adoption of gas chromtaogrpahy systems in oil & gas industries is expected to boost the market growth during the forecast period. Columns, that form the most important part of the chromatography systems, are expected to command the largest market share in 2020 The chromatography instruments market, by consumable & accessory is broadly segmented into column, column accessories, autosampler, autosampler accessories, flow management accessories, solvents/reagents/adsorbents, chromatography fittings and tubing, detectors, mobile phase accessories, fraction collectors, pressure regulators, and other accessories. The columns segment is expected to occupy large market share owing to the importance of columns in the chromatography systems, as chromatographic separation takes place inside the column. Additionally, growing importance of chromatography tests in drug development, will subsequently upsurge the demand for such chromatography consumables and accessories. Life science industry to witness highest growth during the forecast period The end-user industry is segmented into life science industry, academic & research institutes, oil & gas industry, environmental agencies, food & beverage industry and other end user industries. The life science industry is expected to hold the largest share of the market in 2020 owing to the increasing R&D investment by pharmaceutical & biotechnology companies. This end-user segment is expected to grow rapidly in the coming years due to the use of chromatography in various research applications, bulk drug manufacturing, stabilization of drugs, and qualitative and quantitative pharmaceutical analysis. The North America chromatography instruments market to hold the largest market share in 2020 North America is expected to dominate the global chromatography instruments market in 2020, followed by Europe, whereas the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high regional growth is attributed to the increasing R&D funding in healthcare industries, growing number of preclinical activities by CROs and pharmaceutical companies, upsurge in the number of metabolomics research studies, growing food and agricultural industry in Canada and presence of developed healthcare and research infrastructure. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=1258 Top key Players :- The major players operating in the chromatography instruments market include Agilent Technologies (US), Waters Corporation (US), Shimadzu (Japan), Thermo Fisher Scientific (US), PerkinElmer (US), Merck KGaA (Germany), Phenomenex (US), Bio-Rad Laboratories (US), Cytiva (US), Hitachi (Japan) and Restek Corporation (US) among others. Factors like growing need for effective and early diagnosis, rising global prevalence of targeted, increasing preference for minimally invasive diagnostic procedures, increasing benefits of CT scans, and technological advancements are driving the growth of the market.
The Global CT Scanner Market is projected to reach USD 6.20 Billion by 2022, at a CAGR of 5.4% during the forecast period. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=184364345 Cone beam CT technology segment poised to grow fastest in CT scanner market. On the basis of technology, the CT scanners market is segmented into high-slice CT, mid-slice CT, low-slice CT, and cone beam CT technology. The cone beam CT technology segment is expected to grow faster than the other segments during the forecast period, majorly due to factors like procedural advantages; rising market demand for cosmetic dentistry; and ongoing product development & commercialization across major healthcare markets. Portable CT scanners segment expected to register fastest growth rate in the forecast period. Based on type, the CT scanners market is divided into stationary and portable CT scanners. Portable CT scanners segment is poised to grow faster than the other segment due to increasing number of device installations across major markets, growing application horizons, and the lower switching costs provided by portable CT scanners. North America accounted for the largest share of the CT scanner market Geographically, the CT scanner market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017, which is primarily driven by growth in the aging U.S. population; an increasing public emphasis on minimally invasive & effective disease management strategies; robust reimbursement scenario; increasing adoption of novel applications; and rising public-private investments. Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=184364345 The major players in the CT scanner market are Koninklijke Philips N.V. (Netherlands), GE Healthcare (U.S.), Toshiba Corporation (Japan), Siemens AG (Germany), Hitachi Ltd. (Japan), Shimadzu Corporation (Japan), Samsung Electronics Co., Ltd. (South Korea), Neusoft Medical Systems Co., Ltd. (China), Medtronic plc (Ireland), Shenzhen Anke High-tech Co., Ltd. (Hong Kong), Accuray Incorporated (U.S.), PlanMED (Finland), Koning Corporation (U.S.), Carestream Health Inc. (U.S.), and PointNix Co. Ltd (South Korea). Growth in the market is largely driven by the growing threat of antimicrobial resistance due to the overuse of antibiotics, rising demand for animal-derived products, growing prevalence of zoonotic diseases, rising demand for pet insurance, growing animal health expenditure, and the growing number of veterinary practitioners & their rising income levels in developed economies. The rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives and awareness initiatives for antimicrobial resistance and control offer significant growth opportunities for the market players.
The Veterinary Antimicrobial Susceptibility Testing Market is expected to reach USD 135 million by 2026 from an estimated USD 100 million in 2021, at a CAGR of 6.1%. Ask For PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=50401056 Since the beginning of 2020, the majority of the countries worldwide shut down their borders and limited transportation in a bid to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation. The food-producing animal segment is expected to account for the largest share of the veterinary AST market Based on animal type, the veterinary antimicrobial susceptibility testing market is segmented into food-producing animals and companion animals. The food-producing animals segment accounted for the largest share of the market in 2020. The large share and high growth of this segment can be attributed to the high use of antibiotics in food-producing animals, increasing incidence of antimicrobial resistance, increasing demand for meat and dairy products, rising animal healthcare expenditure in developed countries, and the increasing incidence of disease outbreaks in food-producing animals. This segment is further categorized into cattle, pigs, poultry, and other food-producing animals. Companion animals are further segmented into dogs, cats, horses, and other companion animals. The culture media segment is expected to grow at the highest rate during the forecast period The culture media segment is expected to register the highest growth rate during the forecast period. Growth in this product segment can be attributed to the constant requirement and recurrent purchase of these products for cultivating bacterial isolates under controlled environmental laboratory conditions. The veterinary reference laboratory end-user segment is expected to account for the largest share of the veterinary AST market Based on end users, the veterinary antimicrobial susceptibility testing market is segmented into veterinary reference laboratories, veterinary research institutes and universities, and other end users. Veterinary reference laboratories accounted for the largest share of the market in 2020. The large share of this segment can be attributed to the large number of samples received for AST in reference laboratories from small and large animal practices. This segment is also expected to register the highest growth during the forecast period (2021–2026). Asia Pacific is expected to account for the highest CAGR for players operating in the veterinary AST market. The Asia Pacific region is expected to register the highest CAGR during the forecast period. Growth in pet adoption, increasing awareness about animal health, and the growing per capita animal health expenditure, especially in India and China, contribute to the growth of the APAC veterinary antimicrobial susceptibility testing market. Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=50401056 Top Key Players:- Some of the major players in the veterinary antimicrobial susceptibility testing market include Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Bruker Corporation (US), bioMérieux SA (France), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Neogen Corporation (US), HiMedia Laboratories (India), Mast Group Ltd. (UK), Bioguard Corporation (Taiwan), SSI Diagnostica A/S (Denmark), Condalab (Spain), FASTinov SA (Portugal), Synbiosis (UK), Hardy Diagnostics (US), and Liofilchem Srl (Italy). Growth in this market is largely driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and the high sensitivity of label-free technologies.
The global Label-free Detection Market size is estimated to be USD 431 million in 2020 and projected to reach USD 626 million by 2025, at a CAGR of 7.7%. Ask for PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32435593 Market Segmentation: - On the basis of product & service, the label-free detection market is broadly segmented into instruments, consumables and software & services. The consumables segment is further segmented into biosensor chips, microplates and reagents & kits. In 2019, instruments accounted for the largest share of the label-free detection products market owing to the various technological advancements in label-free detection systems. On the basis of technology, the market is categorized into five technology segments—surface plasmon resonance, bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, and other label-free detection technologies. The surface plasmon resonance segment accounted for the largest share in 2019, due to the high sensitivity of this technology and its wide usage in determining specificity, affinity, and kinetic parameters during the binding of macromolecules. Key Market Drivers: – 1 Introduction of technologically advanced products 2 Growing number of drug discovery programs through academic-industrial partnerships 3 High sensitivity of label-free technologies Regional Analysis: - In 2019, Asia Pacific region accounted for the fastest growing region of the label-free detection market. It is also estimated to grow at the highest CAGR in the label-free detection market during the forecast period, this is mainly due to the rising awareness, increasing government support and funding, and growth in life science research. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=32435593 Top Key Players: - Some of the leading players in the label-free detection market include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer Inc. (US), AMETEK, Inc. (US), HORIBA Ltd. (Japan), Spectris (UK), METTLER TOLEDO (US), Corning Incorporated (US), and Agilent Technologies, Inc. (US) |
AuthorWe are providing and consulting the healthcare Industry Research Report. Archives
March 2022
Categories |